LABSCO SUMMARY
Curated pharma intelligence inside Claude, with its sources intact.
Questions about drugs in development, trials, approvals and licensing deals get answers grounded in AdisInsight's curated content, with the source of each fact kept.
What it is
Springer Nature's server that lets Claude query AdisInsight, its curated pharma intelligence database. Claude retrieves licensed AdisInsight content as it answers and keeps track of where each fact came from.
What you get
- Evidence-linked intelligence on drugs in development
- Clinical trial information, curated by AdisInsight
- Adverse drug reaction case reports
- Regulatory milestones, including drug approvals
- Mergers, acquisitions and licensing opportunities
Requirements
An institutional subscription to both Claude and AdisInsight; it is offered to eligible institutional subscribers, not individuals. It connects through Claude Connectors and keeps your institution's access controls in place.
Setup effort
Paste a URL, then authorize — add the endpoint to your client, then approve the OAuth consent screen